Faga Daniel

President, CEO, DirectorANAPTYSBIO, INC (ANAB) · full profile →Form 4 · filed Mar 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
11
11 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 27, 2026Sell(S)100$65.99$7K496K
Mar 27, 2026Sell(S)3K$65.20$198K496K
Mar 27, 2026Sell(S)3K$64.19$203K499K
Mar 27, 2026Sell(S)3K$63.35$164K502K
Mar 27, 2026Sell(S)1K$62.15$63K505K
Mar 27, 2026Sell(S)550$60.63$33K506K
Mar 27, 2026Sell(S)490$59.62$29K506K
Mar 27, 2026Sell(S)4K$58.62$215K507K
Mar 27, 2026Sell(S)510$56.61$29K513K
Mar 27, 2026Sell(S)3K$57.91$149K511K
Mar 25, 2026Grant(A)34K514K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001673528-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly: